Literature DB >> 21689232

Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion.

Alastair L Young1, Tsuyoshi Igami, Yoshiki Senda, Robert Adair, Shahid Farid, Giles J Toogood, K Rajendra Prasad, J Peter A Lodge.   

Abstract

BACKGROUND: Perihilar cholangiocarcinoma (PHCCA) remains a surgical challenge for which few large Western series have been reported. The aims of this study were to investigate the results of surgical resection for PHCCA and assess how practice has evolved over the past 15 years.
METHODS: A prospectively maintained database was interrogated to identify all resections. Clinicopathological data were analysed for impact on survival. Subsequently, data for resections carried out during the periods 1994-1998, 1999-2003 and 2004-2008 were compared.
RESULTS: Eighty-three patients underwent resection. Trisectionectomy was required in 67% of resections. Overall survival was 70%, 36% and 20% at 1, 3 and 5 years, respectively. Size of tumour, margin (R0) status, lymph node status, distant metastasis, tumour grade, portal vein resection, microscopic direct vascular invasion, T-stage and blood transfusion requirement significantly affected outcome on univariate analysis. Distant metastasis (P = 0.040), percutaneous biliary drainage (P = 0.015) and blood transfusion requirement (P = 0.026) were significant factors on multivariate analysis. Survival outcomes improved and blood transfusion requirement was significantly reduced in the most recent time period. DISCUSSION: Blood transfusion requirement and preoperative percutaneous biliary drainage were identified as independent indicators of a poor prognosis following resection of PHCCA. Longterm survival can be achieved following the aggressive surgical resection of this tumour, but the emergence of a clear learning curve in our analyses indicates that these patients should be managed in high-volume centres in order to achieve improved outcomes.
© 2011 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Year:  2011        PMID: 21689232      PMCID: PMC3133715          DOI: 10.1111/j.1477-2574.2011.00328.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  45 in total

1.  Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma.

Authors:  Noriaki Sagawa; Satoshi Kondo; Toshiaki Morikawa; Shunichi Okushiba; Hiroyuki Katoh
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

2.  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Authors:  Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

3.  Clinical value of additional resection of a margin-positive proximal bile duct in hilar cholangiocarcinoma.

Authors:  Yuji Shingu; Tomoki Ebata; Hideki Nishio; Tsuyoshi Igami; Yoshie Shimoyama; Masato Nagino
Journal:  Surgery       Date:  2009-09-20       Impact factor: 3.982

4.  Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role.

Authors:  Hideki Nishio; Ernest Hidalgo; Zaed Z R Hamady; Kadiyala V Ravindra; Anil Kotru; Dowmitra Dasgupta; Ahmed Al-Mukhtar; K Rajendra Prasad; Giles J Toogood; J Peter A Lodge
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

5.  Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumor).

Authors:  Sander Dinant; Michael F Gerhards; E A J Rauws; Olivier R C Busch; Dirk J Gouma; Thomas M van Gulik
Journal:  Ann Surg Oncol       Date:  2006-04-14       Impact factor: 5.344

6.  Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors.

Authors:  A Nakeeb; H A Pitt; T A Sohn; J Coleman; R A Abrams; S Piantadosi; R H Hruban; K D Lillemoe; C J Yeo; J L Cameron
Journal:  Ann Surg       Date:  1996-10       Impact factor: 12.969

7.  Arterioportal shunting as an alternative to microvascular reconstruction after hepatic artery resection.

Authors:  S Kondo; S Hirano; Y Ambo; E Tanaka; T Kubota; H Katoh
Journal:  Br J Surg       Date:  2004-02       Impact factor: 6.939

Review 8.  Hilar cholangiocarcinoma: current management.

Authors:  Fumito Ito; Clifford S Cho; Layton F Rikkers; Sharon M Weber
Journal:  Ann Surg       Date:  2009-08       Impact factor: 12.969

9.  Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases.

Authors:  Hassan Z Malik; K Rajendra Prasad; Karim J Halazun; Amir Aldoori; Ahmed Al-Mukhtar; Dhanwant Gomez; J Peter A Lodge; Giles J Toogood
Journal:  Ann Surg       Date:  2007-11       Impact factor: 12.969

Review 10.  Impact of blood loss on outcome after liver resection.

Authors:  Marieke T de Boer; I Quintus Molenaar; Robert J Porte
Journal:  Dig Surg       Date:  2007-07-27       Impact factor: 2.588

View more
  17 in total

1.  Principles of surgical resection in hilar cholangiocarcinoma.

Authors:  Emilio Ramos
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

2.  Improved surgical outcomes for hilar cholangiocarcinoma: changes in surgical procedures and related outcomes based on 40 years of experience at a single institution.

Authors:  Ryota Higuchi; Takehiro Ota; Takehisa Yazawa; Hideki Kajiyama; Tatsuo Araida; Toru Furukawa; Tatsuya Yoshikawa; Ken Takasaki; Masakazu Yamamoto
Journal:  Surg Today       Date:  2015-02-05       Impact factor: 2.549

3.  Evaluation of inflammation-based prognostic scores in patients undergoing hepatobiliary resection for perihilar cholangiocarcinoma.

Authors:  Masataka Okuno; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Takashi Mizuno; Junpei Yamaguchi; Masato Nagino
Journal:  J Gastroenterol       Date:  2015-07-18       Impact factor: 7.527

Review 4.  Perihilar cholangiocarcinoma: a surgeon's viewpoint on current topics.

Authors:  Masato Nagino
Journal:  J Gastroenterol       Date:  2012-07-31       Impact factor: 7.527

Review 5.  Perihilar cholangiocarcinoma: Current therapy.

Authors:  Wei Zhang; Lu-Nan Yan
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

Review 6.  Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making.

Authors:  Irinel Popescu; Traian Dumitrascu
Journal:  Langenbecks Arch Surg       Date:  2014-05-20       Impact factor: 3.445

7.  ENBD is Associated with Decreased Tumor Dissemination Compared to PTBD in Perihilar Cholangiocarcinoma.

Authors:  Ryota Higuchi; Takehisa Yazawa; Shuichiro Uemura; Wataru Izumo; Rohan Jagat Chaudhary; Toru Furukawa; Masakazu Yamamoto
Journal:  J Gastrointest Surg       Date:  2017-07-18       Impact factor: 3.452

Review 8.  [Perihilar cholangiocarcinoma (Klatskin tumor)].

Authors:  G A Stavrou; M Donati; S Faiss; R M Jenner; K J Niehaus; K J Oldhafer
Journal:  Chirurg       Date:  2014-02       Impact factor: 0.955

Review 9.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

10.  Liver resection for Bismuth type I and Type II hilar cholangiocarcinoma.

Authors:  Jin Hong Lim; Gi Hong Choi; Sung Hoon Choi; Kyung Sik Kim; Jin Sub Choi; Woo Jung Lee
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.